Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Avi Kapoor

Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket

Section,Of,A,Financial,Newspaper,Titled,Key,Movers

Shares of Telomir Pharmaceuticals Inc (NASDAQ:TELO) rose sharply in pre-market trading after the company released promising preclinical study results for its lead compound, Telomir-1.

In an SEC Form 8-K filing on Monday, the pre-clinical-stage biotechnology company revealed that its lead compound, Telomir-1, was able to reverse abnormal deoxyribonucleic acid (DNA) methylation in aggressive prostate cancer models.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.